| 000 | 01711 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517072423.0 | ||
| 264 | 0 | _c20160223 | |
| 008 | 201602s 0 0 eng d | ||
| 022 | _a1091-4358 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHodgkin, Dominic | |
| 245 | 0 | 0 |
_aManagement of Newer Antidepressant Medications in U.S. Commercial Health Plans. _h[electronic resource] |
| 260 |
_bThe journal of mental health policy and economics _cDec 2015 |
||
| 300 |
_a165-73 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aAntidepressive Agents _xeconomics |
| 650 | 0 | 4 |
_aCitalopram _xeconomics |
| 650 | 0 | 4 |
_aCost Control _xeconomics |
| 650 | 0 | 4 |
_aCost Sharing _xeconomics |
| 650 | 0 | 4 |
_aDesvenlafaxine Succinate _xeconomics |
| 650 | 0 | 4 |
_aDrug Costs _xstatistics & numerical data |
| 650 | 0 | 4 | _aDrug Utilization |
| 650 | 0 | 4 |
_aDuloxetine Hydrochloride _xeconomics |
| 650 | 0 | 4 |
_aFluvoxamine _xeconomics |
| 650 | 0 | 4 |
_aFor-Profit Insurance Plans _xeconomics |
| 650 | 0 | 4 | _aHealth Care Surveys |
| 650 | 0 | 4 |
_aHealth Services Accessibility _xeconomics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsurance Coverage _xeconomics |
| 650 | 0 | 4 |
_aInsurance, Pharmaceutical Services _xeconomics |
| 650 | 0 | 4 |
_aPreferred Provider Organizations _xeconomics |
| 650 | 0 | 4 |
_aPrivate Sector _xeconomics |
| 650 | 0 | 4 |
_aSelegiline _xeconomics |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 |
_aVenlafaxine Hydrochloride _xeconomics |
| 700 | 1 | _aHorgan, Constance M | |
| 700 | 1 | _aCreedon, Timothy B | |
| 700 | 1 | _aMerrick, Elizabeth L | |
| 700 | 1 | _aStewart, Maureen T | |
| 773 | 0 |
_tThe journal of mental health policy and economics _gvol. 18 _gno. 4 _gp. 165-73 |
|
| 999 |
_c25597625 _d25597625 |
||